Cargando…
Further Characterization of the Bifunctional HIV Entry Inhibitor sCD4-FI(T45)
HIV entry into target cells is a highly sequential and time-sensitive process. In recent years, potent HIV Env-targeting antibodies, such as VRC01, have been identified. However, antibodies bind only to a single epitope, and mutations that confer resistance to antibody-mediated inhibition of HIV ent...
Autores principales: | Falkenhagen, Alexander, Joshi, Sadhna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432676/ https://www.ncbi.nlm.nih.gov/pubmed/28624214 http://dx.doi.org/10.1016/j.omtn.2017.04.017 |
Ejemplares similares
-
HIV Entry and Its Inhibition by Bifunctional Antiviral Proteins
por: Falkenhagen, Alexander, et al.
Publicado: (2018) -
Control of HIV Infection In Vivo Using Gene Therapy with a Secreted Entry Inhibitor
por: Falkenhagen, Alexander, et al.
Publicado: (2017) -
Genetic Strategies for HIV Treatment and Prevention
por: Falkenhagen, Alexander, et al.
Publicado: (2018) -
sCD4-17b bifunctional protein: Extremely broad and potent neutralization of HIV-1 Env pseudotyped viruses from genetically diverse primary isolates
por: Lagenaur, Laurel A, et al.
Publicado: (2010) -
Lentiviral expression system for the purification of secreted proteins from human cell cultures
por: Falkenhagen, Alexander, et al.
Publicado: (2016)